IN FOCUS6-8 min read

Could smaller companies have a bright spot despite a gloomy environment?

Investing in smaller capitalisation (small cap) stocks when economic conditions are tough can feel uncomfortable. Yet, history tells us that this can be a good time to start considering whether these companies deserve a place within a diversified portfolio. We analysed data from the past five decades to get some insights from history to test this thought.

LED screen


Robert Starkey
Portfolio Manager, Schroder Investment Solutions

The stock market gazes into the crystal ball

One of the best leading indicators is the stock market itself. This is because investors are not only concerned with today’s headlines, but also how the future will unfold. Investors anticipate how the future might unfold and then transact in company shares accordingly, driving the share price up or down in advance of actual news. This means – for example - when a company announces how much it has grown its sales by, the share price might not change on that day if the company grew by the amount that investors expected.  

What rather tends to send the share price moving on the day is when the announcement is above or below what was expected. Small cap stocks are no different in this way, and this can be a clue to guide us to what may be in store for their future.

What the market expects

Over the past year, the fortunes of large and small companies worldwide have diverged. This was primarily driven by the largest, so-called magnificent seven companies in the US, but also reflects the risks associated with owning smaller companies, which are more sensitive to the economic cycle.

1-year cumulative return for global large vs small companies (USD)


Past performance is not a guide to future performance and may not be repeated. The value of investments and the income from them may go down as well as up and investors may not get back the amounts originally invested.

There are a few reasons investors may favour larger companies in the late phase of an investment cycle.  Larger companies generally have multiple research analysts interpreting their performance which reduces uncertainty, they generally have easier access to finance in times of need, and they have multiple diversified products to sell which helps stabilise their cash flows. This makes larger companies an attractive offering going into an economic slowdown. But as the above performance chart shows, this may have already been acknowledged by the market. The key question is whether small cap stocks may have enough “bad expectations” in their price; we could look to history to guide us.

What does the long-term evidence show

We have crunched the data going back to 1980 to find out. We studied how large and small cap share prices behave during each phase of the investment cycle. The table below shows that investing in small caps when the environment feels uncomfortable has generated good results, when investors take a long-term approach.

Average monthly return in US dollars (%)

Phase of the economic cycle

Small caps

Large caps

Recession and recovery



Expansion and slowdown



Source: Schroders as at October 2023. Past performance is not a guide to future performance and may not be repeated.

While the average returns from small cap and large cap stocks in the expansion and slowdown phases have been similar over this period, small cap stocks have - on average - delivered more than double the returns from large caps through both the recession and recovery phases. However, no two cycles are exactly alike, and the current cycle may provide its own clues as to what may lie in store for investors.

Positioning for the next phase in the economic cycle

While it’s always challenging to identify the exact turning points in any economic cycle, we are starting to see some evidence building that we are closer to a turning point than we have been in the past. Our study provides evidence that you tend to get rewarded for looking ahead to when smaller companies will do well again.

We are starting to find some attractive opportunities among small caps, particularly in regions that have already experienced the pain of higher interest rates. When markets do recognise that a new phase in the investment cycle has begun, stock prices will often change sharply and suddenly. While it’s important to be mindful that investment performance can be hit by increasing the allocation to smaller companies too early, it’s prudent to make sure you have a seat at the table to avoid missing out on small cap performance, which often arrives suddenly.

We are selectively allocating to smaller companies across our investment solutions, with a keen eye on risk management. The focus is on the regions offering the best valuation opportunities, and selecting fund managers who are well equipped to navigate any tough conditions ahead to implement this exposure.

To find out how Schroders can support you, visit our website, contact your usual Schroders’ representative or call our Business Development Desk on 0207 658 3894.


Robert Starkey
Portfolio Manager, Schroder Investment Solutions


Multi-Asset Solutions
Follow us

Please note past performance is not a guide to future performance. The value of an investment and the income from it may go down as well as up and investors may not get back the amount originally invested.

This marketing material is for professional clients only. This site is not suitable for retail clients.

For illustrative purposes only and does not constitute a recommendation to invest in the above-mentioned security / sector / country.

Cazenove Capital is a trading name of Schroders (C.I.) Ltd which is licensed under the Banking Supervision (Bailiwick of Guernsey) Law 2020 and the Protection of Investors (Bailiwick of Guernsey) Law 2020, as amended in the conduct of banking and investment business. Registered address at Regency Court, Glategny Esplanade, St. Peter Port, Guernsey GY1 3UF (No.24546). Schroders (C.I.) Limited, Jersey Branch is regulated by the Jersey Financial Services Commission in the conduct of investment business. Registered address at 40 Esplanade, St. Helier, Jersey JE2 3QB, (No.31076).